Early cardiac changes induced by a hypercaloric western-type diet in “subclinical” obesity

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 310, Issue 6, 2016, Pages H655-H666

  Gonçalves, Nádia ^a   Silva, Ana Filipa ^a   Rodrigues, Patrícia Gonçalves ^a   Correia, Eugénia ^a   Moura, Cláudia ^a,b   Eloy, Catarina ^c   Roncon Albuquerque, Roberto ^a   Falcão Pires, Inês ^a   Leite Moreira, Adelino F ^a,b  

^a University of Porto   (Portugal)

^b Centro Hospitalar Universitário de São João   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

Adipose tissue; Heart; Hypercaloric diet; Inflammation; Remodeling

Indexed keywords

GALECTIN 3; COLLAGEN TYPE 1; COLLAGEN TYPE 3; IL1B PROTEIN, RAT; INTERLEUKIN 1BETA; LEPTIN; MESSENGER RNA; RESISTIN; RETN PROTEIN, RAT; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CARDIAC MUSCLE CELL; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; DIETARY INTAKE; HEART MUSCLE COMPLIANCE; HEART MUSCLE FIBROSIS; HEART MUSCLE RELAXATION; HEART VENTRICLE HYPERTROPHY; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN DIET; ANIMAL; CARDIAC MUSCLE; CARDIOMYOPATHY; CELL SIZE; DIASTOLE; ECHOCARDIOGRAPHY; ECHOGRAPHY; EXTRACELLULAR MATRIX; FIBROSIS; GENETICS; GLUCOSE TOLERANCE TEST; HEART VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; IMMUNOLOGY; INFLAMMATION; INSULIN RESISTANCE; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; WISTAR RAT;

ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; BODY WEIGHT; CARDIOMYOPATHIES; CELL SIZE; COLLAGEN TYPE I; COLLAGEN TYPE III; DIASTOLE; DIET, WESTERN; ECHOCARDIOGRAPHY; EXTRACELLULAR MATRIX; FIBROSIS; GALECTIN 3; GLUCOSE TOLERANCE TEST; INFLAMMATION; INSULIN RESISTANCE; INTERLEUKIN-1BETA; LEPTIN; MYOCARDIUM; MYOCYTES, CARDIAC; OBESITY; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; RESISTIN; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR DYSFUNCTION; VENTRICULAR REMODELING;

EID: 84975912829     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00684.2015     Document Type: Article

References (37)

1. Bays H. Adiposopathy, “sick fat,” Ockham’s razor, and resolution of the obesity paradox. Curr Atheroscler Rep 16: 409, 2014.
2. Calligaris SD, Lecanda M, Solis F, Ezquer M, Gutierrez J, Brandan E, Leiva A, Sobrevia L, Conget P. Mice long-term high-fat diet feeding recapitulates human cardiovascular alterations: an animal model to study the early phases of diabetic cardiomyopathy. PLoS One 8: e60931, 2013.
3. Carbone S, Mauro AG, Mezzaroma E, Kraskauskas D, Marchetti C, Buzzetti R, Van Tassell BW, Abbate A, Toldo S. A high-sugar and high-fat diet impairs cardiac systolic and diastolic function in mice. Int J Cardiol 198: 66-69, 2015.
4. Carbone S, Shah KB, Van Tassell BW, Canada JM, Evans RK, Regan JA, Buzzetti R, Abbate A. Obesity and diastolic heart failure: is inflam-mation the link? Transl Med 3: e124, 2013.
5. Cavalera M, Wang J, Frangogiannis NG. Obesity, metabolic dysfunc-tion, and cardiac fibrosis: pathophysiological pathways, molecular mech-anisms, and therapeutic opportunities. Transl Res 164: 323-335, 2014.
6. Chahal H, McClelland RL, Tandri H, Jain A, Turkbey EB, Hundley WG, Barr RG, Kizer J, Lima JA, Bluemke DA, Kawut SM. Obesity and right ventricular structure and function: the MESA-Right Ventricle Study. Chest 141: 388-395, 2012.
7. Correia-Pinto J, Henriques-Coelho T, Roncon-Albuquerque R Jr, Lourenco AP, Melo-Rocha G, Vasques-Novoa F, Gillebert TC, Leite-Moreira AF. Time course and mechanisms of left ventricular systolic and diastolic dysfunction in monocrotaline-induced pulmonary hypertension. Basic Res Cardiol 104: 535-545, 2009.
8. Dahiya R, Shultz SP, Dahiya A, Fu J, Flatley C, Duncan D, Cardinal J, Kostner KM, Byrne NM, Hills AP, Harris M, Conwell LS, Leong GM. Relation of reduced preclinical left ventricular diastolic function and cardiac remodeling in overweight youth to insulin resistance and inflam-mation. Am J Cardiol 115: 1222-1228, 2015.
9. Eschalier R, Rossignol P, Kearney-Schwartz A, Adamopoulos C, Karatzidou K, Fay R, Mandry D, Marie PY, Zannad F. Features of cardiac remodeling, associated with blood pressure and fibrosis biomark-ers, are frequent in subjects with abdominal obesity. Hypertension 63: 740-746, 2014.
10. Falcao-Pires I, Goncalves N, Moura C, Lamego I, Eloy C, Lopes JM, Begieneman MP, Niessen HW, Areias JC, Leite-Moreira AF. Effects of diabetes mellitus, pressure-overload and their association on myocardial structure and function. Am J Hypertens 22: 1190-1198, 2009.
11. Falcao-Pires I, Palladini G, Goncalves N, van der Velden J, Moreira-Goncalves D, Miranda-Silva D, Salinaro F, Paulus WJ, Niessen HW, Perlini S, Leite-Moreira AF. Distinct mechanisms for diastolic dysfunc-tion in diabetes mellitus and chronic pressure-overload. Basic Res Cardiol 106: 801-814, 2011.
12. Fontes-Carvalho R, Ladeiras-Lopes R, Bettencourt P, Leite-Moreira A, Azevedo A. Diastolic dysfunction in the diabetic continuum: associa-tion with insulin resistance, metabolic syndrome and type 2 diabetes. Cardiovasc Diabetol 14: 4, 2015.
13. Goncalves N, Falcao-Pires I, Leite-Moreira AF. Adipokines and their receptors: potential new targets in cardiovascular diseases. Future Med Chem 7: 139-157, 2015.
14. Horwich TB, Fonarow GC. Glucose, obesity, metabolic syndrome, and diabetes relevance to incidence of heart failure. J Am Coll Cardiol 55: 283-293, 2010.
15. Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, Hu FB, Hubbard VS, Jakicic JM, Kushner RF, Loria CM, Millen BE, Nonas CA, Pi-Sunyer FX, Stevens J, Stevens VJ, Wadden TA, Wolfe BM, Yanovski SZ, Jordan HS, Kendall KA, Lux LJ, Mentor-Marcel R, Morgan LC, Trisolini MG, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC Jr, Tomaselli GF, American College of Cardiology/ American Heart Association Task Force on Practice Guidelines; Obesity Society. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guide-lines and The Obesity Society. Circulation 129: S102-S138, 2014.
16. Kawut SM, Barr RG, Lima JA, Praestgaard A, Johnson WC, Chahal H, Ogunyankin KO, Bristow MR, Kizer JR, Tandri H, Bluemke DA. Right ventricular structure is associated with the risk of heart failure and cardiovascular death: the Multi-Ethnic Study of Atherosclerosis (MESA)-right ventricle study. Circulation 126: 1681-1688, 2012.
17. Kumar A, Thota V, Dee L, Olson J, Uretz E, Parrillo JE. Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med 183: 949-958, 1996.
18. Leite-Moreira AF, Correia-Pinto J, Gillebert TC. Afterload induced changes in myocardial relaxation: a mechanism for diastolic dysfunction. Cardiovasc Res 43: 344-353, 1999.
19. Leite-Moreira AF, Lourenco AP, Roncon-Albuquerque R Jr, Henriques-Coelho T, Amorim MJ, Almeida J, Pinho P, Gillebert TC. Diastolic tolerance to systolic pressures closely reflects systolic performance in patients with coronary heart disease. Basic Res Cardiol 107: 251, 2012.
20. Liu YH, D’Ambrosio M, Liao TD, Peng H, Rhaleb NE, Sharma U, Andre S, Gabius HJ, Carretero OA. N-acetyl-seryl-aspartyl-lysyl-pro-line prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectin. Am J Physiol Heart Circ Physiol 296: H404-H412, 2009.
21. Michas G, Micha R, Zampelas A. Dietary fats and cardiovascular disease: putting together the pieces of a complicated puzzle. Atheroscle-rosis 234: 320-328, 2014.
22. Ndumele CE, Coresh J, Lazo M, Hoogeveen RC, Blumenthal RS, Folsom AR, Selvin E, Ballantyne CM, Nambi V. Obesity, subclinical myocardial injury, and incident heart failure. JACC Heart Fail 2: 600-607, 2014.
23. Panchal SK, Poudyal H, Iyer A, Nazer R, Alam MA, Diwan V, Kauter K, Sernia C, Campbell F, Ward L, Gobe G, Fenning A, Brown L. High-carbohydrate, high-fat diet-induced metabolic syndrome and cardio-vascular remodeling in rats. J Cardiovasc Pharmacol 57: 611-624, 2011.
24. Paulus WJ, Tschope C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remod-eling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 62: 263-271, 2013.
25. Qin F, Siwik DA, Luptak I, Hou X, Wang L, Higuchi A, Weisbrod RM, Ouchi N, Tu VH, Calamaras TD, Miller EJ, Verbeuren TJ, Walsh K, Cohen RA, Colucci WS. The polyphenols resveratrol and S17834 prevent the structural and functional sequelae of diet-induced metabolic heart disease in mice. Circulation 125: 1757-1764, S1-6, 2012.
26. Rider OJ, Lewis AJ, Lewandowski AJ, Ntusi N, Nethononda R, Petersen SE, Francis JM, Pitcher A, Banerjee R, Leeson P, Neubauer S. Obese subjects show sex-specific differences in right ventricular hy-pertrophy. Circ Cardiovasc Imaging 8: e002454, 2015.
27. Sharma N, Okere IC, Duda MK, Johnson J, Yuan CL, Chandler MP, Ernsberger P, Hoit BD, Stanley WC. High fructose diet increases mortality in hypertensive rats compared to a complex carbohydrate or high fat diet. Am J Hypertens 20: 403-409, 2007.
28. Stahrenberg R, Edelmann F, Mende M, Kockskamper A, Dungen HD, Scherer M, Kochen MM, Binder L, Herrmann-Lingen C, Schonbrunn L, Gelbrich G, Hasenfuss G, Pieske B, Wachter R. Association of glucose metabolism with diastolic function along the diabetic continuum. Diabetologia 53: 1331-1340, 2010.
29. Tsai CT, Wu CK, Lee JK, Chang SN, Kuo YM, Wang YC, Lai LP, Chiang FT, Hwang JJ, Lin JL. TNF-alpha down-regulates sarcoplasmic reticulum Ca(2)(+) ATPase expression and leads to left ventricular diastolic dysfunction through binding of NF-kappaB to promoter response element. Cardiovasc Res 105: 318-329, 2015.
30. Van Tassell BW, Arena R, Biondi-Zoccai G, McNair Canada J, Oddi C, Abouzaki NA, Jahangiri A, Falcao RA, Kontos MC, Shah KB, Voelkel NF, Dinarello CA, Abbate A. Effects of interleukin-1 blockade with anakinra on aerobic exercise capacity in patients with heart failure and preserved ejection fraction (from the D-HART pilot study). Am J Cardiol 113: 321-327, 2014.
31. Van Tassell BW, Arena RA, Toldo S, Mezzaroma E, Azam T, Sero-pian IM, Shah K, Canada J, Voelkel NF, Dinarello CA, Abbate A. Enhanced interleukin-1 activity contributes to exercise intolerance in patients with systolic heart failure. PLoS One 7: e33438, 2012.
32. Weigert J, Neumeier M, Wanninger J, Bauer S, Farkas S, Scherer MN, Schnitzbauer A, Schaffler A, Aslanidis C, Scholmerich J, Buechler C. Serum galectin-3 is elevated in obesity and negatively correlates with glycosylated hemoglobin in type 2 diabetes. J Clin Endo-crinol Metab 95: 1404-1411, 2010.
33. World Health Organization. Obesity and Overweight. Geneva: World Health Organization, 2003.
34. 2+ ATPase. Crit Care Med 39: 984-992, 2011.
35. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on prac-tice guidelines. Circulation 128: 1810-1852, 2013.
36. Yang B, Larson DF, Watson R. Age-related left ventricular function in the mouse: analysis based on in vivo pressure-volume relationships. Am J Physiol Heart Circ Physiol 277: H1906-H1913, 1999.
37. Yu L, Ruifrok WP, Meissner M, Bos EM, van Goor H, Sanjabi B, van der Harst P, Pitt B, Goldstein IJ, Koerts JA, van Veldhuisen DJ, Bank RA, van Gilst WH, Sillje HH, de Boer RA. Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis. Circ Heart Fail 6: 107-117, 2013.